Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: More Predictions 2017 Will Be A Banner Year For Deal-Making

Jan 24 2017

• By Joseph Haas and Ying Huang

DealWatch_1200x675

Related Content

J&J's Actelion Courtship Seen Unaffected By Macitentan MAESTRO Failure

Jan 23 2017

Big Pharma Is Back In The M&A Driver’s Seat For 2017

Jan 09 2017

Biogen Pays $1.25bn For Peace Of Mind Over Tecfidera, But Legal Wrangling Continues

Jan 18 2017

Lilly Pays Nearly $1bn To Regain Migraine Candidate It Once Sold For $1m

Jan 19 2017

Takeda Targets Severe Epilepsies In Ovid Alliance

Jan 19 2017

AbbVie Picks Up Dong-A Candidate As It Makes Immuno-Onc Inroads

Dec 29 2016

Pharma Is Ready And Waiting For A Tax Holiday Under Trump

Nov 09 2016

Related Companies

AbbVie Inc.

Genomics Medicine Ireland Ltd.

WuXi AppTec

Zebra Biologics Inc.

Pure Protein LLC

University of Oklahoma

Dong-A Socio Holdings

PharmAthene, Inc.

Altimmune Inc.

The University of Alabama at Birmingham

Theraclone Sciences, Inc.

AMAG Pharmaceuticals Inc.

Palatin Technologies, Inc.

King Pharmaceuticals, Inc.

Novan, Inc.

Sato Pharmaceutical Co., Ltd.

University of North Carolina at Chapel Hill

Evotec SE

Fibrocor Therapeutics L.P.

St. Michael's Hospital

Mount Sinai Health System

Jiangsu NHWA Pharmaceutical Co., Ltd.

Mapi Pharma Ltd.

D-Pharm Ltd.

Johnson & Johnson

Actelion Pharmaceuticals Ltd.

Takeda Pharmaceutical Co. Ltd.

ARIAD Pharmaceuticals, Inc.

Biogen, Inc.

Forward Pharma A/S

CoLucid Pharmaceuticals, Inc.

Eli Lilly and Company

Additional Topics

Deals M & A Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window